Our Analyses showed that the majority of these patients face a substantial amount of adherence barriers, especially with regards to the time commitment to receive the treatment, associated travel/opportunity costs, as well as depressive moods. Nonetheless, by understanding the diverse challenges faced by their patients, physicians have the opportunity to address barriers either directly or via patient consultations.

Read more here: Questionnaire for the assessment of adherence barriers of intravitreal therapy: the ABQ-IVT | International Journal of Retina and Vitreous | Full Text (biomedcentral.com)